Lawrence "Rusty" Hofmann, MD
Dr. Hofmann co-founded Grand Rounds with the goal of ensuring that access to state-of-the-art care is available to everyone, not just the rich and privileged. He is Chief of Interventional Radiology at Stanford Hospital and a Professor of Radiology at the Stanford School of Medicine. A nationally recognized deep venous thrombosis (DVT) expert, Dr. Hofmann has published over 100 articles on acute and chronic DVT, peripheral arterial disease, and interventional oncology. Dr. Hofmann has a BS in Biology from University of Illinois and an MD from Ohio State University College of Medicine, and he did his residency at Johns Hopkins where he was Chief Resident.
Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD), in addition to serving on the Board of several other private companies. Past investments include athenahealth (NASDAQ: ATHN), Illumina (NASDAQ: ILMN) and Sirna Therapeutics (acquired by Merck). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking healthcare investor on Forbes’ Midas List since 2008.
Immediately prior to joining Venrock, Bryan received his PhD in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his BA from Dartmouth College.
Robert R. Schmidt is a Principal on the U.S. Buyout team at The Carlyle Group, focused on private equity investments in the healthcare sector. He is based in New York.
Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Grand Rounds, MedRisk, One Medical, Ortho Clinical Diagnostics and Sedgwick. He is currently a member of the Board of Directors of Grand Rounds, MedRisk, One Medical and Ortho Clinical Diagnostics.
Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on information business services and healthcare investments, and Merrill Lynch Global Private Equity, focused on buyouts in North America.
Mr. Schmidt received his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania.
Kathleen Sebelius is one of America’s foremost experts on national and global health issues, human services and executive leadership. From April 2009 through June 2014, Kathleen served in President Barack Obama’s Cabinet as the 21st Secretary of the Department of Health and Human Services, leading the effort to pass and implement the most significant health reform in half a century–the Affordable Care Act. Kathleen served as Governor of Kansas from 2003 to 2009, and has led numerous ambitious efforts at the state and federal level to provide all Americans with the opportunity and tools to live happier, healthier and more successful lives.
Kathleen currently serves as a senior advisor to Enhanced Pharma, Hampton Creek Inc., and the Aspen Institute, where she co-chairs the Aspen Health Strategy Group. Named by Forbes as one of the 100 most powerful women in the world, Kathleen is a frequent keynote speaker for national and international organizations. Kathleen earned a master of public administration degree from the University of Kansas and a bachelor of arts degree from Trinity Washington University.
James is a Partner at Greylock and invests in mission-driven entrepreneurs who combine technology and human touch to deliver amazing consumer services. James’ current investments include CreativeLive (online creative education), GoFundMe (crowdfunding for personal causes), Lyra Health (software-enabled service for mental health care), and Redfin (tech-enabled real estate brokerage). He invests in online marketplaces, e-commerce, end-to-end consumer services and business-to-business-to-consumer (B2B2C) models. James has backed multiple companies that have scaled from early stages to hundreds of millions in annual revenue. He has also represented Greylock as a Board member of companies that have been acquired by Adobe, Discovery Communications, Facebook, Microsoft, Twitter and Yahoo!.
Prior to Greylock, James was a VP/GM in the Search & Marketplace business unit at Yahoo!. He’s also worked in product development and operations roles in several early-stage consumer technology companies, including Guru (acquired by Unicru), Drugstore.com (acquired by Walgreens), and Wired (acquired by Conde Nast). James has been named several times to the Forbes Midas list, which recognizes top VC tech investors. He graduated from Brown University and Harvard Business School.
As co-founder and CEO of Grand Rounds, Owen believes that patients will achieve better healthcare outcomes through the intersection of technology, medical expertise, and extraordinary patient care. Prior to Grand Rounds, Owen co-founded Reputation.com and grew the company into the worldwide leader in online reputation and privacy management; he also held leadership positions at eBay and Accenture (Health and Life Sciences Practice). Owen received a BA with honors from Trinity College and received an MBA from Stanford Graduate School of Business. Owen’s been recognized among the World Economic Forum’s Global Technology Pioneers, Goldman Sachs’ Top 50 Builders + Innovators and Rock Health’s Most Beloved CEOs.
Dr. Ray Dorsey
Dr. Dorsey is Associate Professor of Neurology at The Johns Hopkins School of Medicine and Director of The Johns Hopkins Parkinson’s Disease and Movement Disorders Center. After receiving a joint MD/MBA at the University of Pennsylvania, Dr. Dorsey completed an NIH-funded fellowship in Movement Disorders and Experimental Therapeutics at the University of Rochester. His research focuses on movement disorders like Parkinson’s and Huntington’s disease and developing new treatments for individuals with these neurological conditions.
Dr. Laura Esserman
Dr. Esserman is Professor of Surgery and Radiology at UCSF School of Medicine and directs the UCSF Carol Franc Buck Breast Care Center. Her research focuses on bioinformatics, medical and clinical informatics, systems integration, and clinical care delivery with the goal of giving patients better access to accurate information to become partners in their healthcare decisions. Dr. Esserman has authored numerous articles in peer-reviewed journals covering all aspects of breast health, advocating the improvement in delivering breast cancer care. She was awarded for her research and collaboration with colleagues when she received the 2005 NCI SPORE Investigator of the Year Award.
Dr. Keith Lillemoe
Dr. Lillemoe is Chairman of Surgery at Massachusetts General Hospital and the W. Austen Professor of Surgery at Harvard Medical School. He is a world-renowned general surgeon and regarded as one of the top pancreatic cancer surgeons in the country. With over four decades in academic medicine, Dr. Lillemoe has previously held leadership positions at Johns Hopkins and Indiana University. His bibliography includes more than 300 scientific articles and 115 book chapters. In addition, he serves as editor of the leading surgical textbook, Greenfield’s Surgery: Scientific Principles and Practices, and as the Editor-in-Chief of the top surgical journal, Annals of Surgery.
Dr. Michael Link
Dr. Link is the Lydia J. Lee Professor in Pediatric Cancer and former Chief of Pediatric Hematology & Oncology at Stanford University School of Medicine. He recently ended his term as President of the American Society of Clinical Oncology (ASCO) and was the first pediatric oncologist to serve in that position. Dr. Link runs multiple clinical trials at Stanford dealing with the treatment of sarcomas of bone and soft tissue, acute lymphoblastic leukemias, and non-Hodgkin’s lymphoma and Hodgkin’s disease. In 2013 he was awarded the visiting lectureship in Pediatric Oncology at the University of Texas MD Anderson Cancer Center.
Dr. Christopher Longhurst
As Chief Information Officer for UC San Diego Health, Dr. Longhurst oversees all operations and strategic planning for information and communications technology. He is also responsible for planning and developing all administrative and clinical information systems related to operating UC San Diego Health hospital and clinical facilities. Dr. Longhurst leads the creation and execution of a comprehensive information strategy to meet future needs of UC San Diego Health along with creating standards, architectures and policies for information technologies across UC San Diego and the UC system. His area of responsibility includes electronic health records and the MyUCSDChart system. UC San Diego Health has reached Stage 7 of electronic medical record (EMR) adoption, a ranking devised by the Healthcare Information and Management Systems Society (HIMSS). This distinction is achieved by less than five percent of U.S. hospitals. Dr. Longhurst is also a key faculty member in the Department of Biomedical Informatics in the UC San Diego School of Medicine. He most recently served as chief medical information officer for Stanford Children’s Health, where he led strategic efforts to improve children’s health and provider workflow using information technology. He also founded and led the clinical informatics fellowship at Stanford, where he was a clinical professor of pediatrics. Dr. Longhurst completed his residency at Stanford Medical School and earned his medical degree and MS in medical informatics from UC Davis. He holds a BS in molecular biology from UC San Diego. He is a board-certified pediatrician and clinical informaticist. The author and co-author of many publications on using technology and data to improve patient care and outcomes, Dr. Longhurst was elected a fellow in the prestigious American College of Medical Informatics.
Dr. Matthew Nielsen
Dr. Nielsen is a board-certified urologic oncologist practicing in the fully integrated Multidisciplinary Genitourinary Oncology Program at the UNC Chapel Hill Lineberger Comprehensive Cancer Center, where he is Director of the Division of Urologic Oncology. His research, focused on cancer care quality and medical decision making, was recognized with the Rising Stars in Urology Research Award and has been supported by the NIH, AHRQ, and the American Cancer Society. Dr. Nielsen received an M.S. in Clinical Research from UNC-Chapel Hill, did his residency at John Hopkins, and his received his M.D. from John Hopkins. He was selected for the American Urological Association Leadership Program and serves on the Scientific Advisory Board for the Bladder Cancer Advocacy Network.
Dr. Lidia Schapira
Dr. Schapira is an Associate Professor of Oncology at the Stanford University Medical Center. Her clinical area of expertise is in breast cancer, new treatments for the disease and the special concerns for young cancer survivors. Her research focuses on the psychosocial support of cancer patients and improved communication between the patient and treating physician. Dr. Schapira has published articles in the leading scientific and academic journals in the field and is a past director of the American Psychosocial Oncology Society.